The genomic and immune landscape of long-term survivors of high-grade serous ovarian cancer
Fewer than half of all patients with advanced-stage high-grade serous
ovarian cancers (HGSCs) survive more than five years after diagnosis, but
those who have an exceptionally long survival could provide insights into
tumor biology and therapeutic approaches.
Read full publication.